First systematic review finds gut-brain axis impacts treatment outcomes in bipolar patients
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Oct-2025 05:11 ET (15-Oct-2025 09:11 GMT/UTC)
The first systematic review on the effects of bipolar medications on the gut microbiome furthers our understanding of the connection between the gut and the brain in patients treated for bipolar disorder.
By analysing existing datasets, researchers concluded that the health of the gut microbiome may predict a patient’s response to treatment with drugs.
The results of the study could pave the way for new personalised therapeutic strategies and inspire further studies and clinical trials focused on treatments with the microbiome in mind.
Nanyang Technological University, Singapore (NTU Singapore) and the World Health Organisation (WHO) are collaborating on a new project to bolster global capabilities in food safety risk assessment, in support of the WHO Global Strategy for Food Safety 2022–2030.
This narrative review published by the Bone and Diabetes Working Group of the International Osteoporosis Foundation (IOF) Committee of Scientific Advisors reveals critical insights into how diabetes mellitus alters bone microarchitecture and influences fracture risk. The paper, titled "Bone microstructure and TBS in diabetes: what have we learned? A narrative review" summarizes alterations in bone microarchitecture measured by HR-pQCT in diabetes. It also addresses the technical and clinical considerations of the trabecular bone score, particularly discussing the significance of this measurement in individuals with diabetes and the influence of abdominal fat.
Recently, Professor Peng Cao's team at Nanjing University of Chinese Medicine conducted an in-depth study on the therapeutic potential of plant-derived extracellular vesicles in inflammatory skin diseases. They proposed a novel strategy for treating psoriasis using Perilla frutescens leaf-derived extracellular vesicle-like particles (PLEVPs), and established a comprehensive research framework encompassing medicinal plant screening, molecular profiling, mechanistic studies, and in vivo validation.
The study revealed that PLEVPs effectively alleviate psoriasis symptoms by delivering the functional miRNA pab-miR396a-5p, which precisely modulates the IL-17 signaling pathway. This regulation reduces inflammation and keratinocyte hyperproliferation, demonstrating strong potential for localized therapy and clinical translation. The findings were published online in the international journal Research, under the title “Perilla frutescens Leaf-Derived Extracellular Vesicle-Like Particles Carry Pab-miR-396a-5p to Alleviate Psoriasis by Modulating IL-17 Signaling.”